Feifei Yan

696 total citations
28 papers, 496 citations indexed

About

Feifei Yan is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Feifei Yan has authored 28 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Feifei Yan's work include Nutritional Studies and Diet (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and PARP inhibition in cancer therapy (3 papers). Feifei Yan is often cited by papers focused on Nutritional Studies and Diet (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and PARP inhibition in cancer therapy (3 papers). Feifei Yan collaborates with scholars based in China, Australia and Sweden. Feifei Yan's co-authors include Peng Shen, Yongping Song, Delong Liu, Shuhang Wang, Weiwei Cui, Shoumeng Yan, Fang Fang, Qi Jiang, Mengye He and Jing Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Feifei Yan

23 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Yan China 12 135 132 122 80 55 28 496
Xiufeng Zheng China 10 111 0.8× 98 0.7× 135 1.1× 47 0.6× 27 0.5× 24 435
Gwon‐Soo Jung South Korea 15 93 0.7× 58 0.4× 229 1.9× 82 1.0× 50 0.9× 27 591
Wenping Lü China 14 149 1.1× 75 0.6× 198 1.6× 44 0.6× 22 0.4× 51 542
Jingbo Li China 11 123 0.9× 74 0.6× 149 1.2× 102 1.3× 62 1.1× 29 494
Zhaoyang Chen China 13 66 0.5× 66 0.5× 136 1.1× 178 2.2× 62 1.1× 51 529
Nan Hu China 12 193 1.4× 297 2.3× 76 0.6× 83 1.0× 34 0.6× 45 584
Geng Xu China 14 147 1.1× 91 0.7× 183 1.5× 36 0.5× 53 1.0× 50 585
Guoqing Zhang China 12 231 1.7× 122 0.9× 183 1.5× 65 0.8× 13 0.2× 42 563
Shenghe Deng China 11 192 1.4× 82 0.6× 106 0.9× 118 1.5× 21 0.4× 44 388
Kaiwen Wang China 12 54 0.4× 85 0.6× 154 1.3× 89 1.1× 15 0.3× 63 477

Countries citing papers authored by Feifei Yan

Since Specialization
Citations

This map shows the geographic impact of Feifei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Yan more than expected).

Fields of papers citing papers by Feifei Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Yan. The network helps show where Feifei Yan may publish in the future.

Co-authorship network of co-authors of Feifei Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Yan. A scholar is included among the top collaborators of Feifei Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Yan. Feifei Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yan, Feifei, et al.. (2024). The symmetric 2-adic complexity of Tang-Gong interleaved sequences from Legendre sequence pair. Cryptography and Communications. 17(1). 167–179.
3.
Yan, Feifei, et al.. (2024). The 4-adic complexity of quaternary sequences with low autocorrelation and high linear complexity. Advances in Mathematics of Communications. 19(4). 1110–1118.
4.
Ye, Chanqi, Xiaoxiao Yan, Xiaomeng Dai, et al.. (2023). Biocompatible snowman-like tumor-targeting dimer nanoparticles for improved delivery efficiency and enhanced anti-tumor therapy. Chemical Engineering Journal. 474. 145766–145766. 9 indexed citations
5.
Yan, Feifei, et al.. (2023). Association between Dietary Inflammatory Index and Sarcopenia: A Meta-Analysis. Nutrients. 15(1). 219–219. 25 indexed citations
6.
Yan, Feifei, et al.. (2023). Prevalence and Risk Factors of Frailty in Stroke Patients: A Meta-Analysis and Systematic Review. The journal of nutrition health & aging. 27(2). 96–102. 18 indexed citations
7.
Ruan, Jian, Shuaishuai Xu, Qiong Li, et al.. (2022). EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma. Briefings in Bioinformatics. 23(6). 8 indexed citations
8.
He, Mengye, et al.. (2022). Long survival after immunotherapy plus paclitaxel in advanced intrahepatic cholangiocarcinoma: A case report and review of literature. World Journal of Clinical Cases. 10(32). 11889–11897. 4 indexed citations
9.
Zheng, Dandan, Qiong Li, Shuaishuai Xu, et al.. (2022). Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers. Cancer Letters. 546. 215853–215853. 18 indexed citations
10.
Zhu, Yufan, Feixiang Chen, Minhao Wu, et al.. (2022). Biocompatible and antibacterial Flammulina velutipes-based natural hybrid cryogel to treat noncompressible hemorrhages and skin defects. Frontiers in Bioengineering and Biotechnology. 10. 960407–960407. 6 indexed citations
11.
Jiang, Qing, Feifei Yan, Chanqi Ye, et al.. (2022). Cancer cell membrane-wrapped nanoparticles for cancer immunotherapy: A review of current developments. Frontiers in Immunology. 13. 973601–973601. 18 indexed citations
12.
Yan, Feifei, Shoumeng Yan, Jing Wang, et al.. (2022). Association between triglyceride glucose index and risk of cerebrovascular disease: systematic review and meta-analysis. Cardiovascular Diabetology. 21(1). 226–226. 59 indexed citations
13.
Yan, Feifei, et al.. (2022). Metastatic urothelial carcinoma harboring ERBB2/3 mutations dramatically respond to chemotherapy plus anti-PD-1 antibody: A case report. World Journal of Clinical Cases. 10(8). 2497–2503. 1 indexed citations
14.
Song, Dandan, Huan He, Indranil Sinha, et al.. (2021). Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor. Cancer Letters. 506. 23–34. 18 indexed citations
15.
Yan, Feifei, Qi Jiang, Mengye He, & Peng Shen. (2021). Parp Inhibitor Treatment of Advanced Breast Cancer Beyond the BRCA -Mutated Type: A Meta-Analysis. Future Oncology. 17(18). 2381–2393. 6 indexed citations
16.
Wang, Shuhang, Yongping Song, Feifei Yan, & Delong Liu. (2016). Mechanisms of resistance to third-generation EGFR tyrosine kinase inhibitors. Frontiers of Medicine. 10(4). 383–388. 78 indexed citations
18.
19.
Chen, Xi, et al.. (2014). Dental Caries Status and Oral Health Behavior Among Civilian Pilots. Aviation Space and Environmental Medicine. 85(10). 999–1004. 4 indexed citations
20.
Yan, Feifei. (2010). Common Algorithms of Association Rules Mining in Data Mining. Computer Technology and Development. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026